Answers are grounded in this paper and cite their sources.
Case-control study reports that MALAT1 gene variants influence non-Hodgkin lymphoma risk, suggesting genetic implications.
The findings suggest that MALAT1 gene polymorphisms, particularly rs3200401 and rs619586, as well as the TCG haplotype, may influence susceptibility to non-Hodgkin lymphoma and serve as potential genetic biomarkers. However, further studies involving larger and ethnically diverse cohorts are required to validate these associations.
No takes yet. Share an insight, caveat, or question.
Mozaffari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: